Extensively reviewed evidence has associated Nrg4 with protective effects against metabolic dysregulation in various metabolic diseases, such as insulin resistance, obesity, NAFLD, and diabetes mellitus through several mechanisms, such as anti-inflammation, autophagy regulation, pro-angiogenesis, and substrate metabolism [35,36]. Here, NRG4 is linked to obesity due to melanocortin 4 receptor deficiency.